We are live on ! Find out more
FPRX

Five Prime Therapeutics, Inc.
FPRX

Delisted

FPRX was delisted on the 15th of April, 2021.

Back to rankings

111 hedge funds and large institutions have $354M invested in Five Prime Therapeutics, Inc. in 2015 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 40 increasing their positions, 34 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 16

18% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 34

4% more funds holding

Funds holding: 107 → 111 (+4)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

30% less capital invested

Capital invested by funds: $504M → $354M (-$150M)

100% less call options, than puts

Call options by funds: $3K | Put options by funds: $634K

Holders
111
Holders Change
+4
Holders Change %
+3.74%
% of All Funds
3.1%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
20
Increased
40
Reduced
34
Closed
16
Calls
$3K
Puts
$634K
Net Calls
-$631K
Net Calls Change
-$221K

Top Buyers

1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$15.1M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$14M
3
GPP
Great Point Partners
Connecticut
+$11.8M
4
AC
Armistice Capital
New York
+$10.9M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$7.22M

Top Sellers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$10.2M
2
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$7.33M
3
BI
BVF Inc
California
-$5.98M
4
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$4.98M
5
AAM
Aureus Asset Management
Massachusetts
-$4.46M
Name Holding Trade Value Shares
Change 		Change in
Stake
Lord, Abbett & Co
26
Lord, Abbett & Co
New Jersey
$2.32M -$2.69M -125,093 -45%
EC
27
EcoR1 Capital
California
$2.29M +$3.2M +149,000 New
TCIM
28
TIAA CREF Investment Management
New York
$2.21M -$41.1K -1,914 -1%
Geode Capital Management
29
Geode Capital Management
Massachusetts
$2.11M +$168K +7,839 +6%
AQR Capital Management
30
AQR Capital Management
Connecticut
$2.01M -$794K -36,930 -22%
RSCM
31
Rock Springs Capital Management
Maryland
$1.85M – – –
SIM
32
Spark Investment Management
New York
$1.83M -$344K -16,000 -12%
Wells Fargo
33
Wells Fargo
California
$1.83M -$670K -31,183 -21%
AIC
34
AWM Investment Company
New York
$1.82M – – –
Bank of New York Mellon
35
Bank of New York Mellon
New York
$1.72M -$283K -13,149 -11%
GAMA
36
Graticule Asia Macro Advisors
New York
$1.66M +$2.31M +107,670 New
TI
37
Telemetry Investments
New York
$1.58M +$1.32M +61,500 +150%
NI
38
Numeric Investors
Massachusetts
$1.55M -$1.54M -71,868 -42%
EAM
39
EverPoint Asset Management
Connecticut
$1.54M -$3.01M -140,000 -58%
CS
40
Candriam SCA
Luxembourg
$1.5M +$2.09M +97,300 New
BA
41
BlackRock Advisors
Delaware
$1.38M -$28.8K -1,338 -1%
Deutsche Bank
42
Deutsche Bank
Germany
$1.36M +$18.8K +876 +1%
Allianz Asset Management
43
Allianz Asset Management
Germany
$1.21M +$31.5K +1,468 +2%
BIM
44
BlackRock Investment Management
Delaware
$1.17M -$6.08K -283 -0.4%
GCP
45
GSA Capital Partners
United Kingdom
$1M +$1.14M +53,085 +441%
WMSA
46
Weiss Multi-Strategy Advisers
New York
$1M +$322K +15,000 +30%
D.E. Shaw & Co
47
D.E. Shaw & Co
New York
$868K -$3.15M -146,369 -72%
OC
48
Oppenheimer & Co
New York
$769K +$139K +6,451 +15%
Macquarie Group
49
Macquarie Group
Australia
$739K +$1.03M +48,000 New
NFA
50
Nationwide Fund Advisors
Ohio
$727K -$16.3K -760 -2%
1
2
3 4 5

FPRX Hedge Fund Activity: Q3 2015 in Review

111 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Five Prime Therapeutics, Inc. (FPRX) for Q3 2015, worth a combined $354M — down 30% from $504M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new FPRX positions and 16 closed out — a net gain of 4 holders — while 40 added to existing stakes and 34 trimmed.

The largest buyer was Adage Capital Partners, adding an estimated $15.1M. The largest seller was Point72 Asset Management, cutting an estimated $10.2M.

  • 111 institutional investors held Five Prime Therapeutics, Inc. (FPRX) as of Q3 2015, up from 107 in Q2 2015.
  • Funds reported $354M of Five Prime Therapeutics, Inc. stock for Q3 2015, down 30% quarter-over-quarter.
  • 20 funds opened new Five Prime Therapeutics, Inc. positions in Q3 2015 and 16 closed out, a net change of +4 holders.
  • The largest Five Prime Therapeutics, Inc. buyer in Q3 2015 was Adage Capital Partners, an estimated $15.1M added.
  • The largest Five Prime Therapeutics, Inc. seller in Q3 2015 was Point72 Asset Management, an estimated $10.2M sold.

Based on aggregated 13F filings for Q3 2015.